Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma

Steven D Hassenfeld Children's Center - New York University, New York

Columbia University Children's Hospital of New York Presbyterian Child & Adolescent Oncology Center, New York

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

Penn State Hershey Children's Hospital, Hershey

Children's National Medical Center - D.C. Center for Cancer and Blood Disorders, Washington D.C.

Johns Hopkins University School of Medicine, Baltimore

Emory University Children's Healthcare of Atlanta Aflac Cancer Center & Blood Disorders, Atlanta

University of Miami, Miami

University of Alabama at Birmingham Dept. of Pediatric-Hematology/Oncology, Birmingham

Amplatz Children's Hospital University of Minnesota Medical Center- Pediatric Hematology Oncology, Minneapolis

Children's Medical Center, Dallas Center for Cancer and Blood Disorders, Dallas

Children's Hospital Center for Cancer and Blood Disorders, Aurora

Center for Cancer and Blood Disorders-Phoenix Children's Hospital, Phoenix

Children's Hospital of Orange County (CHOC), Orange

Stanford University and Lucile Packard Children's Hospital, Palo Alto

Oregon Health & Sciences University Doembecher Children's Hospital, Portland

Dana-Farber Cancer Institute Department of Pediatric Neuro-oncology, Boston

University of Wisconsin Pediatric Hematology/Oncology Department, Madison

Strollery Children's Hospital Division of Hematology/Oncology, Edmonton

Children's and Women's Health Center of BC Division of Hematology/ Oncology/ BMT, Vancouver

Hospital for Sick Children, Toronto

Birmingham Children's Hospital, Birmingham

Royal Hospital for Sick Children, Glasgow

Paediatric Oncology and Haematology Offices, Leeds

Alder Hey Children's NHS Foundation Trust Department of Oncology, Liverpool

Royal Manchester Children's Hospital Ward 84, Manchester

University of Nottingham Children's Brain Tumour Research Centre, Nottingham

Royal Marsden Hospital, Sutton